Source: European Parliament
Question for written answer E-002570/2025
to the Commission
Rule 144
Ioan-Rareş Bogdan (PPE)
The recent report published by the European Union Drugs Agency (EUDA) highlights an alarming trend: the significant increase in the availability of new psychoactive substances (NPS) in the European Union.
These substances, which are often synthetic and whose effects are unknown or have not been sufficiently researched, are posing an increasing challenge to public health, health insurance systems and prevention policies in the Member States.
In recent years, the illegal drug market in Europe has become increasingly fragmented and also ever more sophisticated, harnessing online distribution channels, social networks, encrypted trading platforms and express delivery postal services.
Of particular concern is the emergence of new synthetic opioids, some of which can be far more toxic than traditional substances and which are difficult to detect using current monitoring systems.
- 1.What measures does the Commission intend to take to support Member States in their efforts to swiftly identify and control new psychoactive substances?
- 2.Is the Commission prepared to propose an updated legislative framework to combat the online distribution of synthetic drugs, particularly through the dark web and social media channels?
- 3.How does the Commission plan to incorporate this issue into the future European drugs strategy, in view of the rapid developments in the fields of synthetic chemistry and digital trade?
Submitted: 25.6.2025